IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 133 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $8,000 | -20.0% | 420 | -4.3% | 0.00% | 0.0% |
| Q3 2021 | $10,000 | -9.1% | 439 | +4.5% | 0.00% | 0.0% |
| Q2 2021 | $11,000 | -15.4% | 420 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $13,000 | -31.6% | 420 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $19,000 | +35.7% | 420 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $14,000 | +75.0% | 420 | -40.0% | 0.00% | -50.0% |
| Q3 2018 | $8,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,674,299 | $65,948,000 | 5.28% |
| Ghost Tree Capital, LLC | 700,000 | $17,262,000 | 5.05% |
| Perceptive Advisors | 11,489,772 | $283,337,000 | 4.12% |
| Prosight Management, LP | 274,761 | $6,776,000 | 3.73% |
| Fairmount Funds Management LLC | 389,588 | $9,607,000 | 3.49% |
| Avoro Capital Advisors LLC | 8,500,000 | $209,610,000 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 374,495 | $9,235,000 | 3.26% |
| Ally Bridge Group (NY) LLC | 406,986 | $10,036,000 | 2.95% |
| Parametrica Management Ltd | 146,362 | $3,609,000 | 2.70% |
| COMMODORE CAPITAL LP | 362,869 | $8,948,000 | 2.36% |